ZHYBF — Zhong Yuan Bio-Technology Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Zhong Yuan Bio-Technology Holdings, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2020 March 31st	C2021 March 31st	R2022 March 31st	R2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1.22	1.64	2.33	1.66	2.28
Cost of Revenue
Gross Profit	0.963	1.35	1.91	1.52	2.07
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	1.31	1.65	3.01	3.36	2.01
Operating Profit	-0.086	-0.015	-0.686	-1.7	0.267
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.087	-0.028	-0.672	-1.68	0.271
Provision for Income Taxes
Net Income After Taxes	-0.087	-0.028	-0.683	-1.67	0.272
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-0.087	-0.028	-1.13	-2.15	0.302
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.087	-0.028	-1.13	-2.15	0.302
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.005	-0.002	-0.04	-0.088	0.017